Karl Johnson

647 total citations
27 papers, 372 citations indexed

About

Karl Johnson is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Karl Johnson has authored 27 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in General Health Professions. Recurrent topics in Karl Johnson's work include Risk and Safety Analysis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and HIV/AIDS Research and Interventions (4 papers). Karl Johnson is often cited by papers focused on Risk and Safety Analysis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and HIV/AIDS Research and Interventions (4 papers). Karl Johnson collaborates with scholars based in United States, United Kingdom and Australia. Karl Johnson's co-authors include Seth A. Berkowitz, Sanjay Basu, David W. Dowdy, Hojoon Sohn, Barry S. Solomon, Kristen Hassmiller Lich, Gavin Churchyard, María E. Mayorga, Hilary K. Seligman and Raymond Smith and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Epidemiology.

In The Last Decade

Karl Johnson

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Johnson United States 11 130 106 92 75 63 27 372
Bey‐Marrié Schmidt South Africa 15 134 1.0× 177 1.7× 102 1.1× 31 0.4× 116 1.8× 47 530
Richard Schabas Canada 11 113 0.9× 61 0.6× 104 1.1× 70 0.9× 30 0.5× 19 356
John Buresh United States 7 111 0.9× 49 0.5× 32 0.3× 37 0.5× 46 0.7× 11 336
Sajjad Rahimi Pordanjani Iran 10 90 0.7× 35 0.3× 38 0.4× 56 0.7× 11 0.2× 44 356
Peter Howley Australia 14 51 0.4× 76 0.7× 15 0.2× 13 0.2× 8 0.1× 44 567
Wafa Dhouib Tunisia 7 132 1.0× 35 0.3× 48 0.5× 121 1.6× 52 0.8× 34 395
Haley Stone Australia 7 48 0.4× 41 0.4× 49 0.5× 54 0.7× 16 0.3× 17 256
Andreas Gerber‐Grote Germany 11 29 0.2× 104 1.0× 77 0.8× 16 0.2× 43 0.7× 26 403
Megan Knaus United States 9 25 0.2× 93 0.9× 66 0.7× 16 0.2× 38 0.6× 12 407
Aaron Katz United States 12 82 0.6× 148 1.4× 68 0.7× 9 0.1× 10 0.2× 37 371

Countries citing papers authored by Karl Johnson

Since Specialization
Citations

This map shows the geographic impact of Karl Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Johnson more than expected).

Fields of papers citing papers by Karl Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Johnson. The network helps show where Karl Johnson may publish in the future.

Co-authorship network of co-authors of Karl Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Johnson. A scholar is included among the top collaborators of Karl Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Johnson. Karl Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryckman, Theresa, Karl Johnson, Jacob Creswell, et al.. (2024). Active case-finding of tuberculosis compared with symptom-driven standard of care: a modelling analysis. International Journal of Epidemiology. 53(2).
2.
Johnson, Karl, et al.. (2024). Local Public Health Strategies for Addressing Social Determinants of Health—Analysis of Recent Community Health Improvement Plans. Journal of Public Health Management and Practice. 30(6). 823–831.
3.
Johnson, Karl, et al.. (2023). AI TOOLS FOR HUMAN RELIABILITY ANALYSIS. 437–452. 2 indexed citations
4.
Johnson, Karl, et al.. (2023). Local Health Department Values and Organizational Authorities Guiding Cross-Sector Work During COVID-19. Health Promotion Practice. 25(4). 589–601. 1 indexed citations
6.
Johnson, Karl, Caitlin B. Biddell, Kristen Hassmiller Lich, et al.. (2022). Use of Modeling to Inform Decision Making in North Carolina during the COVID-19 Pandemic: A Qualitative Study. MDM Policy & Practice. 7(2). 97863114–97863114. 5 indexed citations
7.
Rosenstrom, Erik, Julie S. Ivy, María E. Mayorga, et al.. (2022). Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?. PNAS Nexus. 1(1). pgab004–pgab004. 6 indexed citations
8.
Biddell, Caitlin B., Karl Johnson, Mehul D. Patel, et al.. (2022). Cross-sector decision landscape in response to COVID-19: A qualitative network mapping analysis of North Carolina decision-makers. Frontiers in Public Health. 10. 906602–906602. 5 indexed citations
9.
Zhang, Ye, Virginia Wiseman, Tanya Applegate, et al.. (2022). Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in Australia. Frontiers in Medicine. 9. 839479–839479. 7 indexed citations
10.
Johnson, Karl, Caitlin B. Biddell, Kristen Hassmiller Lich, et al.. (2022). Organizational decision‐making during COVID‐19: A qualitative analysis of the organizational decision‐making system in the United States during COVID‐19. Journal of Contingencies and Crisis Management. 31(2). 259–272. 2 indexed citations
11.
Johnson, Karl, et al.. (2021). Identification of human errors and influencing factors: A machine learning approach. Safety Science. 146. 105528–105528. 32 indexed citations
12.
Johnson, Karl, et al.. (2021). A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders. Genetics in Medicine. 24(2). 262–288. 5 indexed citations
13.
Jo, Youngji, Karl Johnson, David W. Dowdy, et al.. (2021). Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia. PLoS ONE. 16(9). e0256531–e0256531. 17 indexed citations
14.
Basu, Sanjay, Karl Johnson, & Seth A. Berkowitz. (2020). Use of Machine Learning Approaches in Clinical Epidemiological Research of Diabetes. Current Diabetes Reports. 20(12). 80–80. 22 indexed citations
15.
Ong, Jason J., Richard De Abreu Lourenço, Deborah J. Street, et al.. (2020). The Preferred Qualities of Human Immunodeficiency Virus Testing and Self-Testing Among Men Who Have Sex With Men: A Discrete Choice Experiment. Value in Health. 23(7). 870–879. 17 indexed citations
17.
Hole, Michael K., et al.. (2019). Medical-Financial Partnerships: Cross-Sector Collaborations Between Medical and Financial Services to Improve Health. Academic Pediatrics. 20(2). 166–174. 44 indexed citations
18.
Johnson, Karl, et al.. (2018). “In the Clinic They Know Us”: Preferences for Clinic-Based Financial and Employment Services in Urban Pediatric Primary Care. Academic Pediatrics. 18(8). 912–919. 13 indexed citations
19.
Jaganath, Devan, et al.. (2018). Desirability of Clinic-Based Financial Services in Urban Pediatric Primary Care. The Journal of Pediatrics. 202. 285–290. 14 indexed citations
20.
Johnson, Karl, Gavin Churchyard, Hojoon Sohn, & David W. Dowdy. (2018). Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings. Clinical Infectious Diseases. 67(7). 1072–1078. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026